1560 Investors following Matrix Lab. Share this News with them.
0
Like this story, share it with millions of investors on M3
Matrix Lab gets USFDA nod for HIV treatment capsules
Matrix Laboratories has received the U.S. FDA's approval for atazanavir sulfate capsules, according to information available on the drug regulator's website on Thursday.
Matrix Laboratories has received the U.S. FDA's approval for atazanavir sulfate capsules, according to information available on the drug regulator's website on Thursday.
Atazanavir sulfate capsules are used in the treatment of HIV infection.